14 Feb
by Vitaliy Dadalyan
In a regulatory filing detailing its U.S.-listed investments as of Dec. 31, Berkshire also said it took a new 648,000 share stake in drugmaker Biogen Inc worth $192.4 million, and significantly reduced its stakes in two major banks, Wells Fargo & Co and Goldman Sachs Group Inc. Berkshire has sold more than 86 million shares, or 21%, of its Wells Fargo stake since June 30, as the bank tries to restore its reputation following scandals over its mistreatment of customers. Berkshire began investing in Wells Fargo in 1989.
